Ziarco Appoints Mike Grey as Executive Chairman of Board of Directors
July 20, 2015 08:00 ET
|
Ziarco Group Ltd.
CANTERBURY, United Kingdom, July 20, 2015 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced the appointment of Mike Grey as...
Ziarco Initiates Phase 2a Clinical Trial of ZPL-389 in Atopic Dermatitis
June 10, 2015 08:00 ET
|
Ziarco Group Ltd.
CANTERBURY, England, June 10, 2015 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced that it has dosed the first patient in its...
Ziarco Announces Appointment of Dr. Pablo Jimenez as Chief Medical Officer
June 08, 2015 08:00 ET
|
Ziarco Group Ltd.
CANTERBURY, UK, June 8, 2015 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a clinical-stage biopharmaceutical company focusing on inflammatory skin diseases, today announced the appointment of Pablo Jimenez,...
Ziarco Announces Appointment of Mike Grey to Board of Directors
December 01, 2014 08:00 ET
|
Ziarco Group Ltd.
CANTERBURY, UK, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced the addition of Mike Grey to its Board of...
Ziarco Raises $33.1 Million in Series B Financing
November 10, 2014 07:00 ET
|
Ziarco Group Ltd.
CANTERBURY, England, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Ziarco Group Ltd, a biopharmaceutical company focusing on inflammatory skin diseases, today announced the completion of a $33.1 million Series B...